Are you Dr. Farrell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Silver Spring, MD 20993Phone+1 301-796-2330
Summary
- Dr. Ann Farrell, MD is a hematologist in Silver Spring, Maryland. She is currently licensed to practice medicine in Massachusetts and Connecticut.
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1993 - 1996
Yale-New Haven Medical CenterResidency, Internal Medicine, 1986 - 1989
Rush Medical College of Rush University Medical CenterClass of 1986
Certifications & Licensure
MA State Medical License 1993 - 2026
CT State Medical License 1989 - 1999
Publications & Presentations
PubMed
- 337 citationsFDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable SuspensionEdvardas Kaminskas, Ann T. Farrell, Yong-Cheng Wang, Rajeshwari Sridhara, Richard Pazdur
The Oncologist. 2005-03-01 - 225 citationsFDA Approval: Blinatumomab.Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, Carolyn L. Yancey, Reyes Candau-Chacon
Clinical Cancer Research. 2015-09-15 - 69 citationsThe Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff, Caroline C. Sigman, Hervé Avet-Loiseau
Clinical Cancer Research. 2017-08-01
Press Mentions
FDA Approves Hympavzi for HemophiliaOctober 15th, 2024- FDA Approves First Once-Weekly Drug Treatment Regimen for HemophiliaOctober 11th, 2024
- FDA Approves Oral Agent for Anemia in Dialysis PatientsFebruary 15th, 2023
- Join now to see all
